| |
| | Practice Standard for the Administration of Exogenous Surfactant (SURVANTA) |
 | | One may consider continued treatment with additional doses of surfactant (total of 4 doses maximum) for preterm infants with RDS and worsening oxygenation 6-12 hours after the second dose. |
 | | There is no contraindication to following another type of exogenous surfactant given at an outside institution (e.g., Exosurf) with the NICU standard dose of Survanta. |
 | | Couser, RJ, Ferrara, TB, Ebert, J, Hoekstra, RE, Fangman, JJ: Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. |
| neonatal.peds.washington.edu /NICU-WEB/surf.stm (639 words) |
|